Schonfeld Strategic Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-69,144
| Closed | -$556K | – | 1926 |
|
|
2025
Q1 | $556K | Buy |
69,144
+14,144
| +26% | +$114K | ﹤0.01% | 1421 |
|
|
2024
Q4 | $494K | Sell |
55,000
-3,500
| -6% | -$31.4K | ﹤0.01% | 1350 |
|
|
2024
Q3 | $429K | Buy |
+58,500
| New | +$429K | ﹤0.01% | 1362 |
|
|
2022
Q4 | – | Sell |
-104,500
| Closed | -$787K | – | 2496 |
|
|
2022
Q3 | $787K | Buy |
104,500
+58,300
| +126% | +$439K | 0.01% | 1429 |
|
|
2022
Q2 | $465K | Buy |
+46,200
| New | +$465K | ﹤0.01% | 1331 |
|
|
2021
Q4 | – | Sell |
-51,900
| Closed | -$1.15M | – | 1965 |
|
|
2021
Q3 | $1.15M | Buy |
51,900
+24,500
| +89% | +$542K | 0.01% | 839 |
|
|
2021
Q2 | $355K | Buy |
27,400
+6,700
| +32% | +$86.8K | ﹤0.01% | 1322 |
|
|
2021
Q1 | $269K | Buy |
+20,700
| New | +$269K | ﹤0.01% | 1332 |
|
|
2020
Q4 | – | Sell |
-92,100
| Closed | -$1.36M | – | 1522 |
|
|
2020
Q3 | $1.36M | Buy |
+92,100
| New | +$1.36M | 0.03% | 584 |
|
|
2020
Q1 | – | Sell |
-312,268
| Closed | -$6.33M | – | 1138 |
|
|
2019
Q4 | $6.33M | Buy |
+312,268
| New | +$6.33M | 0.15% | 161 |
|